Gland Pharma Limited

Price Chart

Risk-Adjusted Performance

Gland Pharma Limited (GLAND) Price Performance

Gland Pharma Limited (GLAND) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR1797.40, up 3.56% from the previous close.

Over the past year, GLAND has traded between a low of INR1626.60 and a high of INR2022.80. The stock has lost 7.3% over this period. It is currently 11.1% below its 52-week high.

Gland Pharma Limited has a market capitalization of $297.04B, with a price-to-earnings ratio of 35.10 and a dividend yield of 1.04%.

About Gland Pharma Limited

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro-intestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain/analgesics, respiratory and pulmonology, and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier compilation, technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.